abm drug discovery
PD-L1 CRISPR Stable Knockout CT26 Cell Line | T6237
- SKU:
- T6237
- Availability:
- 5 to 7 Days Shipment
Description
abm | PD-L1 CRISPR Stable Knockout CT26 Cell Line | T6237
PD-L1 and PD-1 form a well-known immune-inhibiting complex that helps prevent the over-activation of the immune system. Studies have shown upregulation of PD-L1 in tumour cells as a countermeasure to suppress immune attacks. However, the extensive molecular mechanism of such interaction has not been thoroughly investigated. PD-L1 CRISPR Stable Knockout CT26 Cell Line presents a useful tool to study PD-1/PD-L1-blocking therapy.
Biosafety:
II
Organism:
Mouse
Source Organ:
Colon
Growth Properties:
Adherent
Morphology:
Epithelial-like
Clones:
N/A
Passage Number:
N/A
Population Doner:
24 - 34 hours
Seeding Density:
N/A
Markers:
PD-L1 knockout
Applications:
For Research Use Only
Doner Gender:
N/A
Donor Ethnicity:
N/A
Knockdown Method:
N/A
Induction:
N/A
Overexpression:
N/A
Freeze Thaw:
N/A
Propagation:
The base medium for this cell line is Prigrow V medium available at abm
Preservation:
1. Freeze Medium: 90% FBS and 10% DMSO.
2. Storage Temperature: Liquid nitrogen vapour phase.
Quality Control:
1) In vitro proliferation assay; 2) Flow cytometry
Tumorgenicn:
N/A
Shipping Conditions:
Dry Ice
Storage Contidions:
-180°C